MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Home・Aktien・Vivani Medical

Vivani Medical

Open

1.05 5

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.02

Max

1.08

Schlüsselkennzahlen
By Trading Economics
Einkommen	-103K -6.6M
Angestellte	37

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+275% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	11. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-31M 73M
Vorheriger Eröffnungskurs	-3.95
Vorheriger Schlusskurs	1.05

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Apr. 2026, 17:11 UTC

Wichtige Markttreiber

Wichtige Nachrichtenereignisse

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2. Apr. 2026, 17:10 UTC

Wichtige Nachrichtenereignisse

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

3. Apr. 2026, 00:00 UTC

Wichtige Nachrichtenereignisse

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2. Apr. 2026, 23:47 UTC

Market Talk

Wichtige Nachrichtenereignisse

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2. Apr. 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2. Apr. 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2. Apr. 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2. Apr. 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2. Apr. 2026, 21:01 UTC

Wichtige Nachrichtenereignisse

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2. Apr. 2026, 20:59 UTC

Akquisitionen, Fusionen, Übernahmen

Starbucks and Boyu Capital Finalize China JV

2. Apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. Apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

2. Apr. 2026, 20:41 UTC

Ergebnisse

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2. Apr. 2026, 20:32 UTC

Market Talk

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2. Apr. 2026, 20:30 UTC

Akquisitionen, Fusionen, Übernahmen

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2. Apr. 2026, 20:09 UTC

Market Talk

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2. Apr. 2026, 20:01 UTC

Akquisitionen, Fusionen, Übernahmen

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2. Apr. 2026, 19:46 UTC

Market Talk

Is Oil the New GameStop? -- Market Talk

2. Apr. 2026, 19:35 UTC

Market Talk

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2. Apr. 2026, 19:29 UTC

Akquisitionen, Fusionen, Übernahmen

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2. Apr. 2026, 19:24 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2. Apr. 2026, 19:20 UTC

Market Talk

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2. Apr. 2026, 19:01 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2. Apr. 2026, 19:00 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific: Agreement Reached With American Train Dispatchers Association

2. Apr. 2026, 18:24 UTC

Akquisitionen, Fusionen, Übernahmen

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2. Apr. 2026, 17:44 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2. Apr. 2026, 17:32 UTC

Wichtige Nachrichtenereignisse

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2. Apr. 2026, 17:26 UTC

Ergebnisse

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2. Apr. 2026, 17:17 UTC

Market Talk

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2. Apr. 2026, 17:09 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

275% Vorteil

12-Monats-Prognose

Durchschnitt 3.75 USD 275%

Hoch 4 USD

Tief 3.5 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vivani Medical – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.